Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the efficacy of atezolizumab (Atezo) + carboplatin (Carb) + etoposide (Etop) compared with placebo + Carb + Etop in the intent-to-treat (ITT) population as measured by investigator-assessed progression-free survival (PFS) according to Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) • To evaluate the efficacy of Atezo + Carb + Etop compared with placebo + Carb + Etop in the ITT population as measured by overall survival (OS)
Critère d'inclusion
- Small Cell Lung Cancer